Antisense compounds targeted to connexins and methods of use thereof

Details for Australian Patent Application No. 2004294824 (hide)

Owner Coda Therapeutics (NZ) Ltd

Inventors Not Given

Agent Spruson & Ferguson

Pub. Number AU-A-2004294824

PCT Pub. Number WO2005/053600

Priority 529936 03.12.03 NZ

Filing date 3 December 2004

Wipo publication date 16 June 2005

International Classifications

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

Event Publications

6 July 2006 PCT application entered the National Phase

  PCT publication WO2005/053600 Priority application(s): WO2005/053600

24 March 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004294835-Methods of generating stem cells and embryonic bodies carrying diseasecausing mutations and methods of using same for studying genetic disorders

2004294820-Multi-ticket lottery system